(Q46504299)

English

Interactions of lipoprotein(a) with diabetes mellitus, apolipoprotein B and cholesterol enhance the prognostic values for coronary artery disease

scientific article published in January 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18598204

Interactions of lipoprotein(a) with diabetes mellitus, apolipoprotein B and cholesterol enhance the prognostic values for coronary artery disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18598204

0 references

1 reference

based on heuristic

inferred from title

author name string

Mehdi Rasouli

1

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18598204

Asadollah Mohseni Kiasari

2

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18598204

publication date

1 January 2008

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18598204

Clinical Chemistry and Laboratory Medicine

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18598204

46

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18598204

5

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18598204

667-673

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18598204

Lipoprotein (a) as a predictor of coronary heart disease: the PRIME Study

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.137

21 January 2018

Lipoprotein(a) further increases the risk of coronary events in men with high global cardiovascular risk

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.137

21 January 2018

Association of fibrinogen and lipoprotein(a) as a coronary heart disease risk factor in men (The Quebec Cardiovascular Study).

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.137

21 January 2018

Lipoprotein(a) in American Indians is low and not independently associated with cardiovascular disease. The Strong Heart Study

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.137

21 January 2018

Relation of serum lipoprotein(a) concentration and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.137

21 January 2018

Relation of lipoprotein(a) as coronary risk factor to type 2 diabetes mellitus and low-density lipoprotein cholesterol in patients > or =65 years of age (The Italian Longitudinal Study on Aging).

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.137

21 January 2018

Serum calcium and phosphorus associate with the occurrence and severity of angiographically documented coronary heart disease, possibly through correlation with atherogenic (apo)lipoproteins

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.137

21 January 2018

AHA/ACC scientific statement: Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.137

21 January 2018

Lipoprotein(a) as a risk factor for cardiovascular mortality in type 2 diabetic patients: a 10-year follow-up study

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.137

21 January 2018

Lipoprotein(a), type 2 diabetes and vascular risk in coronary patients

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.137

21 January 2018

Association of lipoprotein(a) levels and apolipoprotein(a) phenotypes with coronary artery disease in Type 2 diabetic patients and in non-diabetic subjects

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.137

21 January 2018

Plasma lipoprotein Lp(a), markers of haemostasis and inflammation, and risk and severity of coronary heart disease

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2008.137

21 January 2018

Identifiers

10.1515/CCLM.2008.137

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18598204

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/18598204

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46504299&oldid=2114560684"